Cholesterol-responsive NFE2L1-INSIG1 interaction controls VLDL secretion and metabolic dysfunction-associated steatohepatitis pathogenesis in mice.

Shijun Deng,Jessica E Freed,Grace Y Lee,Gizel Askin,Zhe Cao,Özgür Cakici,Bo Yuan,Sheng Tony Hui,Karen E Inouye,Isabel Graupera,Gökhan S Hotamışlıgil
{"title":"Cholesterol-responsive NFE2L1-INSIG1 interaction controls VLDL secretion and metabolic dysfunction-associated steatohepatitis pathogenesis in mice.","authors":"Shijun Deng,Jessica E Freed,Grace Y Lee,Gizel Askin,Zhe Cao,Özgür Cakici,Bo Yuan,Sheng Tony Hui,Karen E Inouye,Isabel Graupera,Gökhan S Hotamışlıgil","doi":"10.1172/jci197094","DOIUrl":null,"url":null,"abstract":"Cholesterol overload contributes to metabolic dysfunction-associated steatohepatitis (MASH) progression. One major pathway that limits hepatic cholesterol accumulation is export via VLDL secretion. While sterol regulatory element-binding protein (SREBP) activity is suppressed by insulin-induced gene 1 (INSIG1) under high sterol conditions, VLDL secretion nonetheless persists to prevent lipotoxicity and liver injury, presenting an unresolved paradox in cholesterol sensing and lipoprotein export. Here, we identified a cholesterol-responsive interaction between nuclear factor erythroid 2 related factor-1 (NFE2L1) and INSIG1 that preserved cholesterol homeostasis by sustaining VLDL secretion. Liver-specific NFE2L1 deletion elevated INSIG1 abundance, suppressed SREBP1 activation, and impaired VLDL secretion, leading to hepatic cholesterol accumulation and liver injury. Mechanistically, NFE2L1 bound to INSIG1 via its N-terminal homology box 2 (NHB2) domain; free cholesterol strengthened this interaction to promote INSIG1 degradation, thereby enabling SREBP1 activation and VLDL export. In NFE2L1-deficient mice, WT NFE2L1, but not a mutant NFE2L1 form unable to interact with INSIG1 (NHB2-deleted mutant, ΔNHB2), restored SREBP1 activity and VLDL secretion. Lipidomics analysis revealed that NFE2L1 deficiency reduced serum triglyceride composition, which was restored exclusively by WT NFE2L1. In a murine MASH model, NFE2L1 overexpression activated SREBP1/2, lowered hepatic cholesterol, and attenuated liver injury, inflammation, and fibrosis, without elevating atherogenic lipoproteins owing to compensatory LDL receptor upregulation. Together, these findings explain how VLDL secretion capacity was maintained under cholesterol excess and identify the NFE2L1/INSIG1 axis as a sterol-responsive safeguard for hepatic lipid homeostasis and a potential therapeutic target for MASH.","PeriodicalId":520097,"journal":{"name":"The Journal of Clinical Investigation","volume":"24 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Clinical Investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1172/jci197094","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Cholesterol overload contributes to metabolic dysfunction-associated steatohepatitis (MASH) progression. One major pathway that limits hepatic cholesterol accumulation is export via VLDL secretion. While sterol regulatory element-binding protein (SREBP) activity is suppressed by insulin-induced gene 1 (INSIG1) under high sterol conditions, VLDL secretion nonetheless persists to prevent lipotoxicity and liver injury, presenting an unresolved paradox in cholesterol sensing and lipoprotein export. Here, we identified a cholesterol-responsive interaction between nuclear factor erythroid 2 related factor-1 (NFE2L1) and INSIG1 that preserved cholesterol homeostasis by sustaining VLDL secretion. Liver-specific NFE2L1 deletion elevated INSIG1 abundance, suppressed SREBP1 activation, and impaired VLDL secretion, leading to hepatic cholesterol accumulation and liver injury. Mechanistically, NFE2L1 bound to INSIG1 via its N-terminal homology box 2 (NHB2) domain; free cholesterol strengthened this interaction to promote INSIG1 degradation, thereby enabling SREBP1 activation and VLDL export. In NFE2L1-deficient mice, WT NFE2L1, but not a mutant NFE2L1 form unable to interact with INSIG1 (NHB2-deleted mutant, ΔNHB2), restored SREBP1 activity and VLDL secretion. Lipidomics analysis revealed that NFE2L1 deficiency reduced serum triglyceride composition, which was restored exclusively by WT NFE2L1. In a murine MASH model, NFE2L1 overexpression activated SREBP1/2, lowered hepatic cholesterol, and attenuated liver injury, inflammation, and fibrosis, without elevating atherogenic lipoproteins owing to compensatory LDL receptor upregulation. Together, these findings explain how VLDL secretion capacity was maintained under cholesterol excess and identify the NFE2L1/INSIG1 axis as a sterol-responsive safeguard for hepatic lipid homeostasis and a potential therapeutic target for MASH.
胆固醇反应性NFE2L1-INSIG1相互作用控制小鼠VLDL分泌和代谢功能障碍相关的脂肪性肝炎发病机制。
胆固醇超载有助于代谢功能障碍相关脂肪性肝炎(MASH)的进展。限制肝脏胆固醇积累的一个主要途径是通过VLDL分泌出口。尽管在高胆固醇条件下,胰岛素诱导基因1 (INSIG1)抑制了固醇调节元件结合蛋白(SREBP)活性,但VLDL的分泌仍然可以防止脂肪毒性和肝损伤,这在胆固醇感知和脂蛋白输出中提出了一个尚未解决的悖论。在这里,我们确定了核因子红系2相关因子-1 (NFE2L1)和INSIG1之间的胆固醇反应性相互作用,通过维持VLDL分泌来保持胆固醇稳态。肝脏特异性NFE2L1缺失升高INSIG1丰度,抑制SREBP1激活,损害VLDL分泌,导致肝脏胆固醇积累和肝损伤。机制上,NFE2L1通过其n端同源盒2 (NHB2)结构域与INSIG1结合;游离胆固醇加强了这种相互作用,促进INSIG1降解,从而使SREBP1激活和VLDL输出。在NFE2L1缺失的小鼠中,WT NFE2L1,而不是不能与INSIG1相互作用的突变型NFE2L1 (nhb2缺失的突变体,ΔNHB2),恢复了SREBP1的活性和VLDL的分泌。脂质组学分析显示,NFE2L1缺乏降低了血清甘油三酯的组成,而这种组成仅由WT NFE2L1恢复。在小鼠MASH模型中,NFE2L1过表达激活SREBP1/2,降低肝脏胆固醇,减轻肝损伤、炎症和纤维化,而不因补偿性LDL受体上调而升高致动脉粥样硬化脂蛋白。总之,这些发现解释了在胆固醇过量的情况下VLDL分泌能力是如何维持的,并确定了NFE2L1/INSIG1轴作为肝脏脂质稳态的胆固醇反应性保障和MASH的潜在治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书